Boston Scientific Corporation vs Workiva Inc — how do they compare? Boston Scientific Corporation trades at $50.99 (market cap $74.19B), while Workiva Inc trades at $68.83 (market cap $3.76B). The key difference: Boston Scientific Corporation is far larger — about 19.7× Workiva Inc's market cap, and Workiva Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | WK | |
|---|---|---|
Market Cap | $74.19B | $3.76B |
Sector | Health | Technology |
52-Week High | $108.14 | $93.31 |
52-Week Low | $42.63 | $44.31 |
Enterprise Value | $86.27B | $3.73B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →